Company intelligence / Profile preview

Ra Medical Systems

Carlsbad, California, United Statesx.com ↗

Ownership: Private
Development stage: Commercial

Overview

Ra Medical Systems developed and commercialized excimer laser systems for dermatological and vascular diseases. Its DABRA catheter received FDA clearance for minimally invasive endovascular treatment of peripheral artery disease. The Pharos Excimer Laser was FDA-cleared for psoriasis and atopic dermatitis. The company also launched the VIVO™ non-invasive mapping system for cardiac electrophysiology procedures and filed for CE Mark approval on the LockeT suture retention product. As of mid/late–2023, the company shifted focus to cardiac electrophysiology under the new name Catheter Precision.

Therapeutic areas: CardiovascularDermatologyHematology
Modalities: DeviceLaser-based therapyCatheter-based therapyImaging technology
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Ra Medical Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ra Medical Systems.

Explore the full profile